471 results on '"Karim, Salim S. Abdool"'
Search Results
2. The Lancet Commission on lessons for the future from the COVID-19 pandemic
3. Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
4. A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary health care clinics in South Africa
5. Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
6. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial
7. Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa
8. Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa.
9. Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa
10. Threatening the Future of Global Health — NIH Policy Changes on International Research Collaborations
11. EDITORIAL : HIV—No time for complacency
12. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women
13. Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa
14. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
15. Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants
16. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study
17. Expert consensus statement on the science of HIV in the context of criminal law
18. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
19. Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection
20. Acceptability of Early Antiretroviral Therapy Among South African Women
21. Vaccine inequity and hesitancy persist—we must tackle both
22. Building on Pasteur's legacy: producing vaccines in Africa
23. HIV-1 Superinfection Resembles Primary Infection
24. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis
25. Genital Inflammation and the Risk of HIV Acquisition in Women
26. Differences in HIV Type 1 Neutralization Breadth in 2 Geographically Distinct Cohorts in Africa
27. Y Chromosome and HIV DNA Detection in Vaginal Swabs as Biomarkers of Semen and HIV Exposure in Women
28. Rapid Disease Progression in HIV-1 Subtype C–Infected South African Women
29. Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial
30. Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
31. Bacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1—Negative Women
32. Nelson R. Mandela (1918-2013)
33. Long COVID: a review and proposed visualization of the complexity of long COVID.
34. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa.
35. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
36. Mucosal Escherichia coli Bactericidal Activity and Immune Mediators Are Associated With HIV-1 Seroconversion in Women Participating in the HPTN 035 Trial
37. Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel
38. Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk
39. Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
40. EDITORIAL: An AIDS-Free Generation?
41. Symptomatic Vaginal Discharge Is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in High-Risk Women in South Africa
42. CAPRISA 004 Tenofovir Microbicide Trial: No Impact of Tenofovir Gel on the HIV Transmission Bottleneck
43. Genital Tract Inflammation During Early HIV-1 Infection Predicts Higher Plasma Viral Load Set Point in Women
44. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
45. Duffy-Null—Associated Low Neutrophil Counts Influence HIV-1 Susceptibility in High-Risk South African Black Women
46. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
47. Threatening the Global AIDS Response -- Obstacles to PEPFAR's Reauthorization.
48. Co-enrollment in multiple HIV prevention trials — Experiences from the CAPRISA 004 Tenofovir gel trial
49. HIV prevention transformed: the new prevention research agenda
50. HIV pre-exposure prophylaxis implementation in Africa: some early lessons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.